SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from ChronoScale Holdings Corp (CHRN) (CIK 0001549084) (CHRN) — Aug 6, 2012

ChronoScale Holdings Corp (CHRN) (CIK 0001549084)
Date: Aug. 6, 2012 · CIK: 0001549084 · Accession: 0001165527-12-000803

AI Filing Summary & Sentiment

File numbers found in text: 333-181229

Date
August 6, 2012
Author
President & Director
Form
CORRESP
Company
ChronoScale Holdings Corp (CHRN) (CIK 0001549084)

Letter

PN MED GROUP INC. San Isidro 250, depot 618, Santiago, Chile 8240400 Tel: 569-659-22350 Fax: 775-981-9001 Email: pnmedgroup@gmail.com -------------------------------------------------------------------------------- August 6, 2012 Mr. H. Roger Schwall, Assistant Director U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.C. 20549

Re: PN Med Group Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed July 11, 2012 File No. 333-181229

Dear Mr. Schwall:

This letter shall serve as the request of PN Med Group Inc., pursuant to Rule 461, to accelerate the effectiveness of the above-referenced Registration Statement to Monday, August 6, 2012, 4:30PM EST, or the soonest practicable date thereafter.

The Company further acknowledges the following:

* Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

* The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

* The Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Sincerely,
/s/ Pedro Perez Niklitschek
-------------------------------------
Pedro Niklitschek
President & Director

Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
                                PN MED GROUP INC.
                           San Isidro 250, depot 618,
                             Santiago, Chile 8240400
                               Tel: 569-659-22350
                                Fax: 775-981-9001
                           Email: pnmedgroup@gmail.com
--------------------------------------------------------------------------------

                                                                  August 6, 2012

Mr. H. Roger Schwall, Assistant Director
U.S. Securities and Exchange Commission
Division of Corporate Finance
100 F Street, NE
Washington, D.C. 20549

Re: PN Med Group Inc.
    Amendment No. 4 to Registration Statement on Form S-1
    Filed July 11, 2012
    File No. 333-181229

Dear Mr. Schwall:

This letter shall serve as the request of PN Med Group Inc., pursuant to Rule
461, to accelerate the effectiveness of the above-referenced Registration
Statement to Monday, August 6, 2012, 4:30PM EST, or the soonest practicable date
thereafter.

The Company further acknowledges the following:

     *    Should the Commission or the staff, acting pursuant to delegated
          authority, declare the filing effective, it does not foreclose the
          Commission from taking any action with respect to the filing;

     *    The action of the Commission or the staff, acting pursuant to
          delegated authority, in declaring the filing effective, does not
          relieve the Company from its full responsibility for the adequacy and
          accuracy of the disclosure in the filing; and

     *    The Company may not assert staff comments and the declaration of
          effectiveness as a defense in any proceeding initiated by the
          Commission or any person under the federal securities laws of the
          United States.

Sincerely,

/s/ Pedro Perez Niklitschek
-------------------------------------
Pedro Niklitschek
President & Director
</TEXT>
</DOCUMENT>